Keyphrases
Lysosomal Enzymes
63%
Oligosaccharides
58%
Heparin Cofactor II
57%
Thrombin
56%
Mannose-6-phosphate Receptor
49%
Mannose-6-phosphate
40%
Myelofibrosis
38%
Mannose
36%
Phosphorylation
35%
Tissue Factor Pathway inhibitor-2 (TFPI-2)
34%
Platelets
32%
Tissue Factor
30%
Heparin
29%
Myeloproliferative Neoplasms
28%
Dermatan Sulfate
25%
Glycoprotein
25%
Lysosome
25%
Sickle Cell Disease
24%
N-acetylglucosamine
24%
Thrombosis
24%
UDP-GlcNAc
24%
Venous Thromboembolism
23%
Retroviral Vector
23%
Gene Therapy
23%
Multiple Myeloma
22%
N-acetylglucosamine-1-phosphotransferase
21%
Hepatocytes
21%
Amino Acids
21%
Hematopoietic Stem Cells
20%
Photosystem II
20%
ADAMTS13
20%
Golgi
20%
Complementary DNA (cDNA)
19%
Factor Xa
19%
Protein Z
19%
Coagulation
19%
Cathepsin D
18%
Glycosaminoglycans
18%
Von Willebrand Factor
18%
Mucopolysaccharidosis VII
18%
High Mannose
18%
Bleeding
17%
Liver
16%
Mannose Oligosaccharide
16%
Glycopeptides
16%
Polycythemia Vera
15%
Fibroblasts
15%
Asparagine-linked Oligosaccharides
15%
Cytoplasmic Tail
15%
Acid Hydrolase
15%
Hemostasis
15%
Protease Inhibitors
15%
Lysosomal Storage Disease
14%
Trans-Golgi Network
14%
GlcNAc-1-phosphotransferase
14%
Ruxolitinib
14%
Hemophilia
14%
Protein Z-dependent Protease Inhibitor
13%
Protein Disulfide Isomerase
13%
Anemia
13%
Binding Site
13%
Overall Survival
13%
Activator protein-1 (AP-1)
13%
Momelotinib
13%
Human Plasma
12%
Neonatal Gene Therapy
12%
Neutrophils
12%
Mucolipidosis III
12%
Lectin
12%
Phosphodiester
11%
Confidence Interval
11%
Insulin-like Growth Factor 2 (IGF2)
11%
Vascular Inflammation
11%
Glycoprotein N
11%
Recombinant
11%
Integrin
11%
Endoplasmic Reticulum
11%
Antitrypsin
11%
Lipoproteins
10%
Rat Liver
10%
Coagulation Inhibitors
10%
Anticoagulation
10%
Thrombus Formation
10%
Tumor
10%
Endothelial Cells
10%
Chinese Hamster Ovary Cells
10%
Phase II Study
9%
β-glucuronidase
9%
Clathrin
9%
Human Pluripotent Stem Cells (hPSCs)
9%
Mucolipidosis
9%
Glycosylation
9%
Carbohydrates
9%
Acute Myeloid Leukemia
9%
Endosome
9%
Antithrombin III (ATIII)
9%
Immunoglobulin
9%
Anticoagulant Activity
9%
ADP-ribosylation Factor
9%
Janus Kinase 2 (JAK2)
9%
Biochemistry, Genetics and Molecular Biology
Enzyme
100%
Oligosaccharide
72%
Mannose 6-Phosphate Receptor
48%
Mannose
44%
Phosphotransferase
38%
Kinase
38%
N-Acetylglucosamine
37%
Thrombin
37%
Tissue Factor Pathway Inhibitor
35%
Glycoprotein
34%
Mannose 6-Phosphate
34%
Heparin Cofactor II
27%
Gene Therapy
27%
Platelet
24%
Uridine Diphosphate
24%
Blood Plasma
23%
Lysosome
23%
Thromboplastin
23%
Amino Acids
22%
N-Terminus
19%
Fibroblast
19%
Hematopoiesis
19%
Cathepsin D
18%
Hepatocyte
17%
Binding Site
17%
Myeloid
17%
Heparin
17%
Retrovirus Vector
16%
ADAMTS13
16%
Asparagine
16%
Prothrombinase
16%
Von Willebrand Factor
16%
Clathrin
15%
Protein Z
15%
Lectin
14%
Stem Cell
14%
Protease Inhibitor
14%
Copurification
14%
Protease
14%
Janus Kinase
13%
C-Terminus
13%
Hematopoietic Cell
12%
Glycopeptide
12%
Mucolipidosis
12%
Acid Hydrolase
11%
ADP Ribosylation Factor
11%
Genetics
11%
Wild Type
11%
Glycosaminoglycan
11%
Haemophilia A
11%
Coagulation System
11%
Factor VIII
10%
Promoter Region
10%
Telomere
10%
Fibrinogen
9%
Protein C
9%
Anabolism
9%
Factor X
9%
Mucopolysaccharidosis
9%
Glycosylation
9%
Phytohaemagglutinin
8%
Exosite
8%
Polysaccharide
8%
Secretion (Process)
8%
Protein Disulfide-Isomerase
8%
Arginine
8%
Factor IX
8%
Cytochrome P450
8%
Precursor
8%
Dictyostelium discoideum
8%
T Cell
8%
Factor XI
7%
Serpin
7%
Hydrolase
7%
Overall Survival
7%
Blood Coagulation Factor
7%
Telomerase
7%
Cancer Cell
7%
Factor VII
7%
Internalization
7%
Cell Membrane
7%
Peptide Sequence
7%
Insulin-Like Growth Factor 2 Receptor
7%
Lysine
7%
Macrophage
7%
Dermatan Sulfate
7%
P53
7%
Beta-Glucuronidase
6%
Palmitoylation
6%
Antithrombin
6%
Hemostasis
6%
Golgi Apparatus
6%
Golgi Membrane
6%
Glucosidase
6%
Integrin
6%
Immunoglobulin Producing Cell
6%
Messenger RNA
6%
Lipid
6%
Sly Syndrome
6%
Sialic Acid
6%
Medicine and Dentistry
Myelofibrosis
28%
Venous Thromboembolism
27%
Myeloproliferative Neoplasm
25%
Diseases
24%
Platelet
23%
Thrombosis
23%
Neoplasm
20%
Sickle-Cell Disease
17%
Gene Therapy
16%
Multiple Myeloma
15%
Bleeding
13%
Malignant Neoplasm
13%
Blood Stasis
12%
Heparin Cofactor II
12%
Janus Kinase
12%
Neutrophil
12%
Overall Survival
12%
Tissue Factor Pathway Inhibitor
12%
Hematopoietic Cell
11%
Anticoagulation
11%
COVID-19
10%
Acute Myeloid Leukemia
10%
Blood Clotting
10%
Hematopoiesis
10%
Mucopolysaccharidosis
10%
Protein Disulfide Isomerase
10%
Polycythemia vera
10%
Integrin
9%
Haemophilia A
9%
Anemia
9%
Momelotinib
8%
Ruxolitinib
8%
Quality of Life
8%
Thromboprophylaxis
8%
Proteinase Inhibitor
8%
Thrombin
7%
Thromboplastin
7%
Hepatocyte
7%
Hematology
7%
Vasculitis
7%
Antithrombotic
7%
Stereotactic Body Radiation Therapy
7%
Hematologic Malignancy
7%
Heparin
7%
Cancer
7%
Retrovirus Vector
6%
Oncology
6%
Thrombocytopenia
6%
Essential Thrombocythaemia
6%
Direct Oral Anticoagulant
6%
Mass Cytometry
6%
Cytokine
6%
Protein Z
6%
Pacritinib
6%
Secondary Acute Myeloid Leukemia
5%
Receptor
5%
In Vitro
5%
Thrombotic Thrombocytopenic Purpura
5%
Mucolipidosis
5%
Dermatan Sulfate
5%
Von Willebrand Factor Cleaving Proteinase
5%
Clinician
5%
Promoter Region
5%
Lung Cancer
5%
Patient with Sickle Cell Disease
5%
Myelodysplastic Syndrome
5%
Thrombocyte Activation
5%
Janus Kinase Inhibitor
5%
Prothrombinase
5%